One Biosciences
Single-cell tumour profiling for oncology teams and pharma and biotech partners, turning routine biopsy samples into clinical insights for treatment selection and drug development.
€3.3Mi-Démo 5 grant (France 2030)
ParticipantB
Bpifrance
Activity from announced rounds
Activity in this selectionUndisclosed
Bpifrance is France’s public investment bank, financing businesses through equity, loans and guarantees and supporting innovation and international expansion.
Its equity activity includes venture capital, growth investment and investments in other funds. Innovation financing can also support research, development and bringing a product to market, so founders may have financing options beyond a conventional equity round.
The appropriate route depends on the project and stage: research funding, a guarantee for borrowing, direct investment and export support serve different needs. Its bank-for-entrepreneurs model connects those instruments with programmes for developing a French business.
Sources
- Rounds participated in
- 3
- Confirmed lead rounds
- 0 1 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $1.4B 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionMAASH
MAASH makes fermentation-derived mycoprotein ingredients for food manufacturers developing meat blends and alternative-protein products.
€12.2MEquity and public financing package
ParticipantMistral AI
Mistral AI develops AI models and computing infrastructure for enterprise and public-sector use.
€1.2BStrategic
Role not disclosed